Unknown

Dataset Information

0

Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.


ABSTRACT: Herein we describe a formulation of self-encapsulating poly(lactic-co-glycolic acid) (PLGA) microspheres for vaccine delivery. Self-healing encapsulation is a novel encapsulation method developed by our group that enables the aqueous loading of large molecules into premade PLGA microspheres. Calcium phosphate (CaHPO4) adjuvant gel was incorporated into the microspheres as a protein-trapping agent for improved encapsulation of antigen. Microspheres were found to have a median size of 7.05 ± 0.31 ?m, with a w/w loading of 0.60 ± 0.05% of ovalbumin (OVA) model antigen. The formulation demonstrated continuous release of OVA over a 49-day period. Released OVA maintained its antigenicity over the measured period of >21 days of release. C57BL/6 mice were immunized via the intranasal route with prime and booster doses of OVA (10 ?g) loaded into microspheres or coadministered with cholera toxin B (CTB), the gold standard of mucosal adjuvants. Microspheres generated a Th2-type response in both serum and local mucosa, with IgG antibody responses approaching those generated by CTB. The results suggest that this formulation of self-encapsulating microspheres shows promise for further study as a vaccine delivery system.

SUBMITTER: Bailey BA 

PROVIDER: S-EPMC5642922 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.

Bailey Brittany A BA   Desai Kashappa-Goud H KH   Ochyl Lukasz J LJ   Ciotti Susan M SM   Moon James J JJ   Schwendeman Steven P SP  

Molecular pharmaceutics 20170822 9


Herein we describe a formulation of self-encapsulating poly(lactic-co-glycolic acid) (PLGA) microspheres for vaccine delivery. Self-healing encapsulation is a novel encapsulation method developed by our group that enables the aqueous loading of large molecules into premade PLGA microspheres. Calcium phosphate (CaHPO<sub>4</sub>) adjuvant gel was incorporated into the microspheres as a protein-trapping agent for improved encapsulation of antigen. Microspheres were found to have a median size of 7  ...[more]

Similar Datasets

| S-EPMC5551544 | biostudies-literature
| S-EPMC6732734 | biostudies-literature
| S-EPMC6513835 | biostudies-other
| S-EPMC7465081 | biostudies-literature
| S-EPMC4769910 | biostudies-literature
| S-EPMC2653259 | biostudies-other
| S-EPMC6631728 | biostudies-literature
| S-EPMC4839968 | biostudies-literature
| S-EPMC5364371 | biostudies-literature
| S-EPMC3580573 | biostudies-literature